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by representative examples in the fields of proteomics, gly-
comics and metabolomics. Finally, general conclusions and 
perspectives are provided.
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Introduction
Capillary electrophoresis–electrospray ionization-mass 
spectrometry (CE-ESI-MS) has emerged as a powerful tool 
for the analysis of charged compounds in biological sam-
ples [1–3]. CE–MS can be used for the characterization of a 
wide variety of analytes, e.g., metabolites, peptides, glycans 
and intact proteins [4–6]. So far, the co-axial sheath–liquid 
interface has been primarily used for the coupling of CE 
to MS [7, 8]. In this design, the sheath–liquid is provided 
co-axially to the end of the CE capillary as a terminal elec-
trolyte reservoir, thereby providing a closed electrical con-
tact (see “Advancements in CE–MS Interface Designs” for 
details). For many applications, this interfacing technique 
provided an acceptable performance and robustness [9–12]. 
However, a limitation of the use of the sheath liquid is that 
it dilutes the CE effluent [13], thereby compromising the 
achievable concentration sensitivity. This may have been 
one of the reasons why CE–MS lagged behind LC–MS in 
the field of proteomics (apart from intact protein analysis), 
glycomics and metabolomics. The low loadability (nL injec-
tion volumes) of CE is also mentioned as an obstacle to 
obtain improved concentration sensitivities and/or low con-
centration detection limits. In order to overcome this issue, 
various chromatographic- and electrophoretic-based precon-
centration techniques have been developed to enhance the 
concentration sensitivity of CE–MS. The reader is referred 
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to more dedicated literature for an overview concerning 
these techniques [14–16].
Recently, the field of CE–MS has benefitted from 
improvements in interfacing designs and, as a result, CE–
MS gained significant interest as a tool for proteomics, 
glycomics, metabolomics and bio-analytical research [2, 
17–19]. These fields can profit from enhanced sensitivity, 
as biological samples often contain many low-abundant 
species and may also be volume-restricted. In this con-
text, the porous tip sheathless interface of Moini [20], the 
flow-through microvial interface of Maxwell et al. [21], 
the electro-osmotic flow (EOF) driven sheath–liquid inter-
face of Wojcik et al. [22], and the porous emitter sheathless 
CE–MS interface of Wang et al. [23] emerged as important 
recent developments. In this paper, a critical and in-depth 
overview of these new interfacing techniques is given, with 
a primary focus related to the level of sensitivity improve-
ment that can be achieved. Attention is devoted to those 
interfaces that gained an increased interest for proteomics 
and metabolomics over the past few years. Furthermore, 
two interfacing techniques are commercially available now, 
i.e. the porous tip sheathless interface and the flow-through 
microvial interface and, therefore, they may have the poten-
tial of becoming broadly used without being an expert user. 
Representative examples illustrate the applicability of the 
new CE–MS approaches in the fields of proteomics (both 
bottom-up and top-down), glycomics and metabolomics. 
Finally, conclusions and perspectives are provided.
Advancements in CE–MS Interface Designs
Soon after the appearance of CE as a liquid-phase ultra-high 
resolution micro-separation technique in 1981 [24], efforts 
to couple CE with MS as an information-rich detection 
method started. Even more so since the short path length of 
spectrophotometric detection in CE provided a limited sen-
sitivity. These efforts culminated in the development of the 
co-axial sheath–liquid ESI interface for CE–MS (sometimes 
also called the triple tube CE–MS interface), which was 
brought to market by Hewlett-Packard (now Agilent Tech-
nologies) in 1995. This interface has been the commercial, 
standard solution for CE–MS interfacing until today. The 
interface couples CE seamlessly to Agilent Technologies 
MS instruments and has been co-used by Bruker to interface 
CE systems to its family of mass spectrometers. Essential 
pre-requisites of this interface were met by both manufac-
turers viz. to share a common ground for both the CE- and 
the electrospray current circuits and to provide the voltage 
for ESI from the MS. Coupling mass spectrometers from 
other manufacturers with CE in which the MS inlet is at 
ground and the ESI-voltage is delivered from the interface 
spray needle is possible but more arduous [25, 26].
Currently, the field of CE–MS interfacing is chang-
ing. New methods that abolish or minimize the usage of a 
sheath liquid have been introduced in the market or are on 
the verge of becoming commercialized.
Requirements for CE-ESI-MS Interfacing
Atmospheric pressure (AP) ESI was first reported by 
Yamashita and Fenn [27] and also by Aleksandrov et al. 
[1, 28]. The method allowed the formation of a spray of 
(sub)micrometer-sized charged droplets under the influ-
ence of an electrical field from which eventually charged 
molecules (ions) enter the MS via the inlet orifice. Initially, 
AP ESI was confined to flow-rates of maximally 10 µL/
min. In order to establish a stable spray at higher flow-rates 
common in HPLC, Bruins et al. [29], Huang et al. [30] 
and Henion [31] came up with an interface concept which 
they called “ion spray” to emphasize the difference of this 
approach with ESI. This approach, where spray formation 
is assisted pneumatically by a co-axially delivered flow 
of nitrogen gas, has become the standard ESI method for 
a wide range of HPLC methods. In HPLC the solvent is 
delivered to the interface by the pump and drives the sol-
utes towards the point of detection. The voltage to establish 
the electrospray field is applied at the outlet spray needle 
in LC–MS. In CE, charged analytes migrate electrophoreti-
cally from the inlet side towards the point of detection and 
into the outlet reservoir under the influence of an electrical 
field. Simultaneously, the background electrolyte (BGE) in 
the capillary may be driven towards the outlet reservoir by 
the EOF. Electrodes in the inlet and outlet reservoir close 
the electrical circuit. When coupling CE to MS, the outlet 
reservoir must be replaced in order to close the electrical 
circuit of the CE system and provide a contact to establish 
electrospray. Therefore, in CE–MS interfacing two electric 
circuits of different magnitude and (sometimes) different 
signs are required to drive the BGE and analytes towards 
the interface and to form the electrospray. The electrical 
circuitry has to manage currents in µA and nA range, direct 
the fields properly and incorporate ground in a safe manner. 
Moreover, like in HPLC–MS, volatile BGEs and solvents 
are generally used in CE–MS to avoid contamination of the 
MS.
Co-Axial Sheath–Liquid CE–MS Interface
Smith et al. [32] were the first to propose the co-axial deliv-
ery of a solvent to the end of the CE separation capillary 
as a terminal electrolyte reservoir. Based on this work, the 
triple tube sprayer was developed by engineers at Hewlett-
Packard. The current design of the co-axial sheath–liquid 
interface is given in Fig. 1. The co-axial sheath–liquid 
CE–MS interface has a number of advantages. The sheath 
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liquid which is added to the CE effluent at a flow-rate of 
typically 1–10 µL/min and the pneumatic assistance ren-
der spray formation independent of BGE composition and 
the presence of the EOF. The sheath–liquid composition 
(typically consisting of aqueous alcohol mixtures with a 
low percentage of a volatile acid like formic or acetic acid) 
dominates ESI chemistry. Thus, one can, for example, sep-
arate the analytes as anions in CE but detect them in their 
cationic form by MS. The sheath liquid is also a crucial 
part of the separation system as it should enable closure of 
the electrical circuit. Consequently, either co- or counter-
ions from the sheath liquid will enter the capillary during 
the separation. If no common ions exist in BGE and sheath 
liquid, depletion phenomena may occur and OH− or H+ 
ions will enter. Overall, this can lead to changes in the CE 
performance (peak widths, migration time order, etc.) [33]. 
The spray needle (Fig. 1) is grounded and as such there is 
a common return path for the CE- and ESI-current. In Agi-
lent and Bruker CE–MS systems the ESI voltage is applied 
on the MS inlet. This interface is compliant with different 
ionization modes besides ESI, such as AP chemical ioniza-
tion and AP photo-ionization. Specific detail of these inter-
faces is the orthogonal orientation of the spray needle to the 
MS inlet orifice which allow neutrals and big droplets pass. 
Bubbles formed by electrolysis in the spray needle are eas-
ily transported out. Over the past decade, the usefulness, 
versatility and robustness of this interface has been dem-
onstrated in various application areas [2, 4, 6, 12, 22, 34]. 
Typical limits of detection (LODs), without usage of pre-
concentration methods, are often in the order of 1 µM in 
sample concentration (depending on the MS method used) 
[9, 11, 35–37].
The co-axial sheath–liquid interface design, how-
ever, compromises sensitivity since the combined EOF 
and sheath–liquid flow is high compared with flow-rates 
used, e.g., in nanoflow HPLC and thus lack the sensitivity 
enhancement occurring in nano-ESI. Based on common 
sheath–liquid flow rate/EOF ratios, volumetric dilutions in 
the order of a factor 100 or more are frequently obtained. 
However, by optimization of the sheath–liquid composi-
tion the sensitivity decrease can be minimized to about 
one order of magnitude as compared to sheathless CE–MS 
in a similar set-up [38]. Moreover, recently the addition 
of reagents to the sheath liquid has been studied for their 
potential to improve the detection of analytes [39]. Impor-
tant to note is that a hydrodynamic flow may occur through 
suction at the capillary end in the interface, especially 
when wider i.d. capillaries (75 and 100 µm) are used. As a 
Fig. 1  a Pictorial representation of Agilent co-axial sheath–liquid 
CE–MS interface: a nebulizing gas, b Sheath liquid, c CE-capillary 
with BGE, d Stainless steel spray needle 0.4 mm i.d., 0.5 mm o.d., 
e outer tube, f ground connection. b Engineering sketch of the co-
axial sheath–liquid CE–MS interface (graphics courtesy from Agilent 
Technologies)
Fig. 2  The porous tip sheathless interface a schematic and b pho-
tograph of the prototype interface. Taken with permission from Ref. 
[41]
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counter measure, the inlet vial must be under-pressurized. 
Therefore, since the introduction of the co-axial sheath–
liquid interface in 1995 efforts have continued to inter-
face CE with MS without delivering a Sheath–liquid, now 
commonly called sheathless CE–MS interfaces. However, 
only in the recent past this work has resulted in practical 
approaches.
Porous Tip Sheathless CE–MS Interface
Moini [20] proposed to etch the end of the CE separation 
capillary with hydrofluoric acid (HF) which renders the end 
of the fused-silica capillary porous. Via this porous sec-
tion small ions and electrons can enter or leave the capil-
lary [40]. The capillary was placed in a stainless steel ESI 
needle. Co-axially a conductive liquid is delivered to the 
outside of the porous end, which makes a hydraulic elec-
trical contact between the ESI needle and the CE separa-
tion BGE. This essential concept has been implemented by 
Beckman Coulter in a prototype system in 2010 (Fig. 2) 
[41], and brought to market very recently (now Sciex Sepa-
rations, CESI 8000). In this set-up, the voltage for electro-
spray can be applied to the spray needle or at the MS inlet 
(depending on the MS). Since the CE capillary is grounded 
through the conductive liquid capillary in the outlet vial 
of the CE, the electrospray voltage is delivered and con-
trolled by the current monitor. To allow the formation of 
the porous tip by HF etching, it is required that the CE cap-
illary has a thin wall. Therefore, the use of 150 µm o.d. and 
30 µm i.d. fused-silica capillaries is practical. As the spray 
is formed solely from the BGE, the usage of positively or 
negatively coated capillaries that generate an EOF has been 
reported or a slight gas pressure on the inlet vial is applied 
when neutrally coated capillaries are used [42].
Though in principle one could use this interface with 
those MS systems that provide the ESI voltage from the 
MS inlet side, this CE–MS interface is at this stage a pro-
prietary solution requiring the usage of Sciex CESI 8000 
system, CE separation capillaries with porous tips and 
mass spectrometers with proper adapters (AB Sciex, 
Thermo and Bruker). Several groups have reported their 
results with the prototype CESI 8000 system [38, 41–44]. 
Using optimized sheath–liquid and sheathless approaches 
in CE–MS, the latter typically provides 10- to 100-fold 
improved concentration sensitivity [38, 42, 43]. The loss 
in sensitivity in sheath–liquid CE–MS can be partly com-
pensated by using capillaries with larger i.d. as they allow 
injection of larger sample amounts. Interestingly, different 
LODs ratios for analytes have been reported when com-
paring the porous tip with the sheath–liquid interface [38]. 
Longevity of the porous tip capillaries of about 200 injec-
tions has been reported [44]. Since the usage of standard 
365 × 50 or × 75 µm i.d. capillaries is prohibited by design 
of the interface, replacement capillaries have to be acquired 
from the manufacturer. This might be considered as a 
potential limitation of this approach since a major benefit 
of CE over other separation techniques, namely the cheap 
capillary, is discarded in this way. Another limitation is 
that this interface can only operate under relatively low CE 
currents (preferably below 10 µA) and therefore the com-
position and concentration of the BGE should be carefully 
considered.
Flow-Through Microvial CE–MS Interface
In a similar way as in the original co-axial sheath–liquid 
CE–MS interface work by the group of Smith et al. [32], 
the group of Maxwell et al. [21] reported a CE–MS inter-
face with a metal spray needle and a co-axially delivered 
modifier [45]. In contrast to Smith, these authors sprayed 
from a 22’ gauge steel needle with optimized exit geom-
etry. The CE separation capillary is moved forward in this 
needle until it stops after which it is pulled back minimally 
to allow a hydraulic liquid connection with the BGE in the 
separation capillary. In the set-up in Fig. 3, the ESI voltage 
is established at the spray needle while the MS entrance is 
at ground. Careful and safe control of the magnitude and 
direction of the electrical fields and of the CE and ESI 
currents is required. The modifier solvent used typically 
consists of aqueous alcohols with 0.1 % acetic acid and 
is delivered at sub µL/min flow-rates. Apart from provid-
ing a wet electrical connection, the modifier solvent flow 
helps align the flow of BGE and sample constituents com-
ing out of the separation capillary towards the needle exit 
[46]. This design allows the usage of standard CE capillar-
ies (365 µm o.d. × 50 µm i.d.) providing stability and ease 
of use of the interface. This interface is now being com-
mercialized by CMP scientific (EMASS-I, http://cmpscient
ific.com/index.html). Recently, Lindenburg et al. [47] com-
pared the flow-through microvial interface with the con-
ventional co-axial sheath–liquid interface for the profiling 
of cationic metabolites. This study revealed slightly better 
sensitivity of the flow-through microvial CE–MS interface. 
Sensitivity was dependent on the flow-rate of the modifier 
solvent. The authors also reported that this interface does 
not tolerate high CE currents as formation of electrolysis 
gases may accumulate in the spray needle and will hamper 
the electrical contact. This implies that the choice of a BGE 
is a critical aspect when working with this interface.
EOF-Driven Sheath–Liquid CE–MS Interface
In a number of publications, Wojcik et al. [22] propagate 
the use of a co-axially, EOF-driven sheath liquid with 
a borosilicate spray tube emitter for CE–MS [48–52]. 
The essential details are given in Figs. 4 and 5. A 
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fused-silica capillary 150 µm o.d. × 10 µm i.d. is used 
for the CE separation. Its end is etched down to 60 µm 
o.d. allowing positioning close to the emitter orifice. The 
borosilicate emitter is home-made from a 1 × 0.75 mm 
glass tube. The emitter orifice is about 8 µm. As capil-
laries from borosilicate glass are known to be less robust 
than fused-silica, modest reliability has been reported 
(personal communication). On the other hand, by using 
10 µm i.d. capillaries in the CE separation the exit 
spray acts as a true nanospray. Exceptional sensitivity is 
reported down to nM in solute concentration in the sam-
ple. Overall, since this design is still not commercial-
ized, its use will be limited to experts in the field. So far, 
this interface has only been used by the Dovichi lab and, 
therefore, for a potential widespread use the performance 
of this approach should be evaluated by other research 
labs as well.
Fig. 3  Schematic overview 
of the flow-through microvial 
interface. Taken with permis-
sion from Ref. [21]
Fig. 4  a Schematic of CE-ESI-MS system; b schematic representa-
tion of the etched capillary in the electrospray emitter; c micrograph 
of the etched capillary in the emitter. Taken with permission from 
Ref. [52]
Fig. 5  CE–MS interface setup with thermo LCQ ion trap mass spec-
trometer. The interface was positioned on a home-made assembly 
used for nano-LC–MS applications
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Porous Emitter CE–MS Interface
Recently, Smith et al. [32] reported an approach to a CE–
MS interface. In the final implementation, they describe a 
fused-silica emitter with a porous tip (90 µm o.d.) which 
is placed inside the separation capillary (365 × 100 µm 
i.d.) and glued to fix its position [23]. The assembly is con-
tained in a T-piece where the assembly of separation and 
emitter capillaries is shifted through a steel tube (1.0 mm 
i.d.). The third leg of the T-piece is connected to a contact 
liquid (2 % acetic acid), which is delivered by a syringe. 
Prior to each run the contact liquid is refreshed. The ESI 
voltage is applied to the steel tube (Fig. 6). Essential in this 
work though is the combination of the narrow i.d. emitter 
with 100 µm i.d. CE separation capillary. In this way, the 
interface eliminates the necessity of working with very nar-
row i.d. separation capillary as in the approaches by Moini 
and Dovichi. As higher currents are in principle present in 
larger bore capillaries, assessing the performance of this 
interface at high CE current conditions should be evaluated. 
The EOF in the separation capillary is suppressed by coat-
ing the inner surface with hydroxyl propyl cellulose. The 
CE separation used is a capillary isotachophoretic (CITP) 
method allowing sample injection up to 2.5 µL or 33 % of 
the volume of the separation capillary. Since the CITP pro-
vides analyte focusing, peptide concentrations down to sub 
nM could be obtained.
Applications
Proteomics
Over the past few years, CE–MS has been extensively used 
for the characterization of proteins and peptides. This has 
been done both on the intact protein level (i.e. top-down 
proteomics), as well as on the peptide level (i.e. bottom-up 
proteomics) [3, 53, 54]. In this section, the potential of CE–
MS using novel interfacing techniques is demonstrated for 
some illustrative proteomics studies. For a comprehensive 
overview of CE–MS-based proteomics studies, we refer to 
the recent reviews of Haselberg et al. [3], Heemskerk et al. 
[53] and Zhao et al. [2].
Top-Down Proteomics
For intact proteins, CE–MS has been most commonly used 
to characterize and identify potential naturally-occurring 
isoforms [55–58] or modifications [59–61] of the protein. 
Since the CE separation is a function of charge, size and 
shape of a compound, small differences in the size or charge 
of proteins may be sufficient for separation. For example, 
protein deamidation replaces an amide by an acidic carbox-
ylic acid moiety leading to a change in pI. Consequently, 
the protein’s electrophoretic mobility changes signifi-
cantly [55]. Moreover, since the species are separated, their 
molecular weight can be determined accurately using MS 
detection. As discussed in “Advancements in CE–MS Inter-
face Designs”, especially when using the conventional co-
axial sheath–liquid CE–MS interface, the required sensitiv-
ity might not be achieved due to dilution of the CE effluent. 
In most studies described above, aqueous solutions with a 
high protein concentration are analyzed and the sensitivity 
of the CE–MS set-up is not a real issue. However, when 
protein concentrations are low or the heterogeneity leads to 
very disperse products the sheath–liquid CE–MS approach 
might not be sensitive enough for detailed characterization. 
It was demonstrated that the porous tip sheathless interface 
can provide LODs for intact proteins that are about two 
order of magnitude lower when compared to the same anal-
ysis performed with a sheath–liquid interface [38]. This 
was attributed to enhanced analyte ionization efficiencies 
and decrease in background noise obtained with the porous 
tip interface. Overall, this enabled the detection of intact 
proteins in the (sub-)nM-range.
In bottom-up proteomics, fragmentation is commonly 
used to sequence separated peptides and, subsequently, 
to identify proteins. For intact proteins, however, that has 
long been a challenge. With the advent of top-down prot-
eomics using techniques like electron-transfer dissociation 
and higher energy collisional dissociation, efficient intact 
protein fragmentation has become achievable. Over the last 
Fig. 6  Schematic view of the 
sheathless porous tip emitter 
design. Taken with permission 
from Ref. [23]
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two years, a few studies have demonstrated that efficient 
CE separations can be combined with a top-down proteom-
ics approach [62–64]. In all cases, coupling was achieved 
using the interface designed by Dovichi. High concentra-
tions of standard proteins (µM-range) were injected to 
demonstrate the feasibility of top-down proteomics in 
CE–MS. Moreover, this approach has also been applied to 
characterize unknown proteins in both cell lysates [62] and 
culture filtrates [63]. No indications about minimum pro-
tein amounts or concentrations required for good sequence 
coverage is given.
Bottom-Up Proteomics
In the field of peptide analysis by CE–MS, bottom-up pro-
teomics applications have been dominant. Since the latest 
update on this topic [53], a few new studies have appeared 
[65–68]. All these studies are from the group of Dovichi 
and, therefore, make use of the EOF driven sheath–liquid 
interface (“Advancements in CE–MS Interface Designs”). 
With this interface good sensitivity can be obtained, allow-
ing peptide identification from Escherichia coli digest 
injections as low as 400 fg [65]. Up to 600 peptides, cor-
responding to 160 proteins, could be identified in this 
study (using 84 ng digest injections). This number could 
be improved by making use of a neutrally-coated capillary 
as it provides higher separation efficiencies and more time 
to obtain tandem mass spectra, resulting in the identifica-
tion of over 1,250 peptides from an injection of 100 ng of 
E. coli digest in a single-shot approach [66]. This was just 
slightly lower than using UPLC–MS/MS and, interestingly, 
complementary peptide identifications were obtained with 
both techniques. Additional sensitivity improvement in the 
CE–MS method was achieved by introducing a sample pre-
concentration approach [67]. By dissolving the sample in a 
buffer of medium pH and using a low-pH BGE, a dynamic 
pH junction was formed where analytes are concentrated. 
With this approach a 10- to 20-fold sensitivity improvement 
was obtained. Until this point, their set-up was not auto-
mated, i.e. requiring manual intervention during CE–MS 
experiments. Recently, the authors introduced an autosam-
pler to allow automation of their analysis [68]. Over eight 
injections, this automated CE–MS system provided aver-
age RSDs for migration time, peak intensity, and peak area 
of 3, 24 and 19 %, respectively, for 340 peptides with high 
intensity. These relatively high numbers were attributed to 
temperature changes in laboratory and evaporation of sol-
vent during the 8 h analysis time. Their system showed to 
be capable of reproducibly identifying over 1,000 peptides 
from an E. coli tryptic digest in a 1-h analysis time.
Tryptic peptide mapping is also routinely used in the 
biotechnology industry to confirm primary sequence 
and to analyze posttranslational modifications of 
recombinantly-produced therapeutics (i.e. biopharmaceu-
ticals). A therapeutic monoclonal antibody was studied by 
tryptic peptide mapping using LC–MS and CE–MS, where 
in the latter case both the sheath liquid and porous tip inter-
face were used [69]. With LC–MS 97 % sequence cover-
age was achieved. The 3 % not covered consisted of 11 
peptides containing 3 or fewer amino acids. Both CE–MS 
systems allowed separation and detection of the 11 small 
peptides. However, with the sheath–liquid CE–MS system, 
one large peptide was not detected due to poor ionization, 
dropping the sequence coverage to 94 %. Employing the 
CE–MS system with the porous tip interface resulted in 
100 % sequence coverage. The porous tip sheathless CE–
MS method using a bare fused-silica capillary provided the 
most optimal resolution, compared to a co-axial sheath–
liquid CE–MS system using both a bare fused-silica and a 
neutrally-coated capillary. This improvement was explained 
by the nebulizing gas used in the sheath liquid interface, 
inducing a laminar flow in the capillary resulting in peak 
broadening. The porous tip sheathless CE–MS system also 
provided significantly less noise as compared to the sheath–
liquid CE–MS system. On the other hand, the sheath–liquid 
CE–MS system proved to have better repeatability in terms 
of migration time and peak height. The porous tip sheath-
less interface was also used for CE–MS impurity profil-
ing of the therapeutic peptide aviptadil [70]. A comparison 
with LC–MS was made; more impurities were detected by 
CE–MS than by LC–MS (15 vs. 2, respectively). Interest-
ingly, none of the impurities found with CE–MS could be 
observed with LC–MS and vice versa. Moreover, LODs 
were about 2,500 times lower with CE–MS as compared 
to LC–MS. Besides characterizing biopharmaceuticals, 
the quantitation of residual host-cell proteins in the for-
mulation is very important. CE–MS using the EOF-driven 
sheath–liquid interface was recently used for this purpose 
[71]. By using isotopically-labeled peptide standards, three 
known host-cell proteins could be confidently quantified at 
the picomole level.
Glycomics
CE–MS is widely used for the analysis of carbohydrates, 
glycoproteins and glycopeptides [72]. Both the porous tip 
interface and the flow-through microvial interface have 
been used for glycomic studies. CE–MS using a porous 
tip sheathless interface in combination with a neutrally-
coated capillary was used to study glycoform profiles of 
intact pharmaceutical proteins [73]. Analysis of human 
erythropoietin revealed more than 250 different iso-
forms (of which 74 glycoforms) with estimated glyco-
form concentrations ranging between 0.53 and 950 nM. 
The isoforms were separated over a 20-min time window 
(Fig. 7a). The separation was mainly due to differences 
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in the number of sialic acid residues, leading to almost 
a 2-min migration time shift with the addition of a sialic 
acid unit (Fig. 7b). Differences in the hexose-N-acetyl-
hexoseamine content also led to small differences in elec-
trophoretic mobility, and thus partial separation. Simi-
larly, the analysis of recombinant human interferon-β-1a 
lead to the assignment of up to 80 isoforms (18 glyco-
forms). The authors compared their results with the litera-
ture and concluded that in comparison with sheath–liquid 
CE–MS similar or improved glycoform coverage of both 
proteins was obtained, while injecting at least ten times 
less sample amount.
Maxwell et al. [74] evaluated the potential of CE–MS 
using a flow-through microvial interface for carbohydrate 
analysis. The authors showed that replacement of the CE 
outlet vial by the flow-through microvial interface for 
coupling to MS did not affect separation by using LIF 
detection measurements, implying that the suction effect 
often reported for sheath–liquid CE–MS is not present 
in this set-up. For the separation of negatively charged 
8-aminopyrene 1,3,6-trisulfonate (APTS)-labeled car-
bohydrates, reverse polarity separations were carried out 
using bare fused-silica capillaries under acidic conditions. 
This approach was also used for the analysis of native and 
APTS-labeled O-acetylated N-glycans in fish serum [75]. 
The method enabled to investigate structural variations 
of O-acetylated sialic acid isomers and was able to dis-
cern between salmons that received a stress treatment and 
controls.
Metabolomics
As CE–MS is an electrodriven-based separation tech-
nique that specifically targets charged analytes, the field 
of metabolomics can benefit greatly from it, since a major 
part of the metabolome is comprised of charged (or charge-
able) compounds [34]. Until now, CE–MS employing the 
co-axial sheath–liquid interface has been primarily used 
for metabolomics studies [18, 76]. Recently, the porous 
tip sheathless interface and the flow-through microvial 
interface have shown good potential to improve the con-
centration sensitivity of CE–MS and as a result the meta-
bolic coverage [43, 47]. For example, Ramautar et al. 
[43] and Hirayama et al. [44] used the porous tip sheath-
less interface for metabolic profiling of human urine. Both 
studies employed fused-silica capillaries and 10 % ace-
tic acid as BGE and reported a significant increase in the 
number of molecular features detected in human urine in 
comparison with the conventional co-axial sheath–liquid 
CE–MS method. Ramautar et al. [43] reported relative 
standard deviations (RSDs) for migration times and peak 
areas of test compounds below 2–12 %, respectively, 
which were comparable with values obtained by sheath–
liquid CE–MS. Furthermore, LODs between 11 and 
120 nM were obtained and the number of molecular fea-
tures was increased threefold as compared to sheath–liquid 
CE–MS (i.e., 900 vs. 300). Hirayama et al. [44] demon-
strated that, in comparison with conventional sheath–liquid 
CE–MS, a fivefold improvement in LODs was obtained 
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with the porous tip sheathless interface for 21 cationic 
metabolite standards, ranging between 4 and 800 nM. 
Application of the method to human urine showed a ten-
fold increase in the number of detected molecular features 
in comparison with conventional CE–MS. The same porous 
tip sheathless CE–MS approach has been used for meta-
bolic profiling of mouse cerebrospinal fluid (CSF), urine 
and plasma, allowing for the detection of circa 350 molecu-
lar features in CSF, circa 400 in mouse plasma and circa 
3,500 features in urine [77]. This demonstrates the suitabil-
ity of the porous tip sheathless CE–MS method for highly 
sensitive metabolic profiling of volume-limited samples. 
CE–MS employing an EOF driven sheath–liquid interface 
or the recent sheathless interfacing design of the group of 
Smith have not been evaluated for metabolomics yet, how-
ever, given the results that were obtained in the field of pro-
teomics (see above), these designs should also be of inter-
est for metabolic profiling studies.
Lindenburg et al. [47] evaluated the performance of 
CE–MS employing a flow-through microvial interface for 
35 cationic metabolites. Figure 8 shows the comparison 
between the flow-through microvial interface and a con-
ventional sheath–liquid CE–MS interface. Using TOF–MS 
for detection, 10 % acetic acid as BGE, and a sheath–liquid 
(75:25 % (v/v) isopropanol/water containing 0.1 % acetic 
acid) flow-rate of 300 nL/min, the authors found that, on 
average, the sensitivity was improved three times and the 
LOD five times (ranging between 10 nM and circa 3 μM). 
Moreover, RSDs for migration times were below 2 %, while 
with sheath–liquid CE–MS RSDs were below 5 %. The 
improvement in migration-time repeatability was explained 
by the lack of a nebulizer gas in the case of the micro-
vial interface and, therefore, the vacuum effect induced 
by the nebulizer was not present. The analysis of a single 
zebrafish embryo resulted in the detection of 110 molecular 
features, which was a twofold improvement as compared 
to sheath–liquid CE–MS. Soliman et al. [78] developed a 
CE–MS method employing a flow-through microvial inter-
face for the analysis of potential prostate cancer biomarkers 
(sarcosine and its isomers, l-proline, l-cysteine, l-leucine, 
l-glutamate, and l-kynurenine) in human urine. CE sepa-
ration was carried out on a positively charged, PEI-coated 
capillary using 2 % formic acid in 50 % methanol as BGE. 
The sheath–liquid was the same as the BGE and was deliv-
ered at a flow rate of 200 nL/min. An excellent separation 
resolution between sarcosine and its isomers was obtained. 
Furthermore, acceptable precision and accuracy of stand-
ard addition calibration of all potential biomarkers were 
obtained, both intra-day and inter-day. Overall, the results 
demonstrated that the flow-through microvial interface can 
be used in repeatable way for metabolite analysis in human 
urine.
The majority of reported CE–MS-based metabolomics 
applications, regardless the used interfacing technology, 
deals with the cationic metabolome. CE–MS with nega-
tive electrospray ionization often results in rather low ana-
lyte responses [79, 80]. The performance of the recently 
introduced CE–MS interfacing techniques with respect to 
improving the analysis of anionic metabolites has not been 
reported yet. It would be highly interesting to evaluate the 
performance of the interfaces for anionic metabolic profil-
ing studies in order to assess their potential for overcoming 
Fig. 8  Multiple extracted 
ion electropherograms of 35 
cationic metabolites (25 μM) 
obtained by CE–MS using a 
flow-through microvial interface 
(upper electropherogram) and 
a sheath–liquid interface (lower 
electropherogram). Taken with 
permission from Ref. [47]
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a major limitation in CE–MS based metabolomics, i.e., 
being the analysis of anionic metabolites. Moreover, the 
newly developed interfaces should all be carefully studied 
with respect to long-term performance and robustness in 
order to evaluate their suitability for clinical metabolomics 
studies that often involve the analysis of hundreds or even 
thousands of biological samples.
Conclusions
In this review, we have described the recently introduced 
CE–MS interfaces that are in our opinion promising for 
enhancing the coverage of the proteome and metabolome 
by CE–MS. Therefore, we have mainly focused on sensi-
tivity. Compared with conventional sheath–liquid CE–MS, 
significant progress has been booked over the past few 
years. Especially the sheathless porous tip interface and the 
flow-through microvial interface emerged as very promis-
ing interfacing techniques for highly sensitive proteomics 
and metabolomics studies at different laboratories. The fea-
sibility of the EOF-driven sheath–liquid interface and the 
recent porous tip emitter interface of the Smith group has 
only been shown in the field of proteomics so far.
In general, the potential of CE–MS in the clinical lab is 
strongly dependent on the reliability, robustness and sensi-
tivity of the interfacing method. As such, the sheath–liquid 
interface approach can be considered a relatively robust and 
routine method for practical usage though with compro-
mised sensitivity. All recently introduced alternatives that are 
described in this review offer enhanced sensitivity compared 
to the sheath–liquid interface, but should be further evalu-
ated with regards to reliability and robustness to assess how 
suitable they will become for routine clinical omics research. 
The sheathless porous tip interface holds the potential of 
most optimal sensitivity but the long-term stability, robust-
ness and ease of use in practice need to be demonstrated. The 
flow-through microvial interface has potential to become a 
viable alternative, however, at present it is still in a relatively 
preliminary stage. For this interface, it was demonstrated 
that it remedies the suction effect that takes place in sheath–
liquid CE–MS. As this effect is known to affect separation, 
we recommend that the other interfaces should be studied 
as well with respect to this. Though, in principle, suction 
from the nebulizer gas cannot occur in the porous tip inter-
face, as there is no nebulizer gas. The recent CE–MS inter-
faces reported by Dovichi and Smith, are at this stage expert 
approaches lacking commercial support.
An important aspect is the versatility of the interfaces. 
The sheath–liquid interface can be used with a relatively 
wide variety of BGEs; this remains to be seen with the 
other interfaces. For example, 1 M formic acid is often 
used as BGE in sheath–liquid CE–MS for the profiling of 
cationic metabolites in biological samples [4]. However, 
this BGE cannot be used at this concentration level with 
the porous tip sheathless and the flow-through microvial 
interface due to the high background currents. In princi-
ple, lower concentrations of this BGE can be employed 
with these interfacing techniques, however, at the expense 
of separation efficiency, which is highly needed for the 
analysis of complex samples. Therefore, 10 % acetic acid 
is used instead of 1 M formic acid, yielding significantly 
lower background currents but comparable separation effi-
ciencies for metabolomics studies [43, 47]. Moreover, an 
interface that can be operated with standard capillaries, i.e., 
±360 μm outer diameter and 50 μm inner diameter, has an 
advantage both in user-friendliness, and in analytical per-
formance as well costs. In order to further expand the role 
of CE–MS in clinical omics studies, the feasibility of the 
new approaches should also be demonstrated for the analy-
sis of anionic compounds using alkaline BGE conditions in 
combination with ESI–MS detection in negative ion mode.
In principle, all interfacing techniques discussed in this 
review can be coupled to an MS of choice, but this requires 
highly skilled users and, often, modification of the MS source. 
In practice, this means that for many end-users the available 
MS equipment will determine the practical application of CE–
MS. From there, the user will be directed to a (commercial) 
solution. The application or type of biological question deter-
mines the type of MS to be used, which then dictates the type 
of interfacing to be employed for CE–MS studies.
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